Genenta Science S.p.A. Stock-Based Compensation
Genenta Science S.p.A. (GNTA) reported Stock-Based Compensation of EUR 1.01 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-04-01
| Period end | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|
| 2025-12-31 | 1.01M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 424.36K EUR 6-K · filed 2025-10-10 | |
| 2024-12-31 | 847.25K EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 232.77K EUR 6-K · filed 2025-10-10 | |
| 2023-12-31 | 739.88K EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 415.43K EUR 6-K · filed 2024-10-29 | |
| 2022-12-31 | 722.74K EUR 20-F · filed 2025-03-28 | |
| 2022-06-30 | 240.04K EUR 6-K · filed 2023-10-20 | |
| 2021-12-31 | 497.10K EUR 20-F · filed 2024-03-29 | |
| 2021-06-30 | 497.10K EUR 6-K · filed 2022-10-25 | |
| 2020-12-31 | 460.19K EUR 20-F · filed 2023-04-21 | |
| 2019-12-31 | 749.51K EUR 20-F · filed 2022-05-02 |